← Back to Research Radar
Academic Publication Academic Publication

Immunotherapy for glioblastoma: current state, challenges, and future perspectives

287
Citations
October 15, 2024
Published Date

Research Abstract & Technology Focus

AbstractGlioblastoma (GBM) is an aggressive and lethal type of brain tumor in human adults. The standard of care offers minimal clinical benefit, and most GBM patients experience tumor recurrence after treatment. In recent years, significant advancements have been made in the development of novel immunotherapies or other therapeutic strategies that can overcome immunotherapy resistance in many advanced cancers. However, the benefit of immune-based treatments in GBM is limited because of the unique brain immune profiles, GBM cell heterogeneity, and immunosuppressive tumor microenvironment. In this review, we present a detailed overview of current immunotherapeutic strategies and discuss the challenges and potential molecular mechanisms underlying immunotherapy resistance in GBM. Furthermore, we provide an in-depth discussion regarding the strategies that can overcome immunotherapy resistance in GBM, which will likely require combination therapies.
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org › academic paper
0%

Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches

Abstract Immune evasion represents a significant challenge in oncology. It allows tumors to evade immune surveillance and destruction, thereby complicating therapeutic interventions and c...

roipad.com › trend story
0%

Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells

Integrated multi-omic profiling of glioblastoma reveals GPNMB as a shared antigen in tumour cells and the surrounding microenvironment, and GPNMB-targeted chimeric antigen receptor T cells demonstr...

crossref.org › academic paper
0%

iMLGAM: Integrated Machine Learning and Genetic Algorithm‐driven Multiomics analysis for pan‐cancer immunotherapy response prediction

AbstractTo address the substantial variability in immune checkpoint blockade (ICB) therapy effectiveness, we developed an innovative R package called integrated Machine Learning and Genetic Algorit...

crossref.org › academic paper
0%

Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells

The rise of drug resistance in cancer cells presents a formidable challenge in modern oncology, necessitating the exploration of innovative therapeutic strategies. This review investigates the late...

crossref.org › academic paper
0%

Cold and hot tumors: from molecular mechanisms to targeted therapy

AbstractImmunotherapy has made significant strides in cancer treatment, particularly through immune checkpoint blockade (ICB), which has shown notable clinical benefits across various tumor types. ...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'Immunotherapy for glioblastoma: current state, challenges, and future perspectives'?

This literature focuses on: AbstractGlioblastoma (GBM) is an aggressive and lethal type of brain tumor in human adults. The standard of care offers minimal clinical benefit, and most GBM patients experience tumor recurrence after treatment. In recent years, significant advan...

Are there open-source GitHub repositories related to Immunotherapy for glioblastoma: current state, challenges, and future perspectives?

Yes, open-source projects like TencentCloud/CubeSandbox (Instant, Concurrent, Secure & Lightweight Sandbox for AI Agents.) are actively building upon these concepts.

What other academic literature is closely related to 'Immunotherapy for glioblastoma: current state, challenges, and future perspectives'?

Yes, highly correlated activity was mapped. An entry titled 'Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches' discusses this: Abstract Immune evasion represents a significant challenge in oncology. It allows tumors to evade immune surveillance and destruction, th...

Are there commercial applications of 'Immunotherapy for glioblastoma: current state, challenges, and future perspectives' in market news publications?

Yes, highly correlated activity was mapped. An entry titled 'Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells' discusses this: Integrated multi-omic profiling of glioblastoma reveals GPNMB as a shared antigen in tumour cells and the surrounding microenvironment, and GPNMB-t...

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

Associated Media Narrative